NCT04914364

Brief Summary

The purpose of this study is to describe balance deficits in patients post COVID-19. The information the investigators learn may help influence balance training exercises for patients post-COVID-19. Participants will have a primary or secondary diagnosis of COVID-19 during hospitalization and off COVID-19 isolation and be receiving care in an acute inpatient hospital. Following consent, participants will complete balance assessments and questionnaires about balance and dizziness in a single session. Vital signs will be monitored during the session.The greatest risks of this study include shortness of breath, and a risk of falling or musculoskeletal soreness.These risks are no greater than those experienced during a usual physical therapy visit.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jul 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 2, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 4, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

July 23, 2021

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 22, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 22, 2022

Completed
2.2 years until next milestone

Results Posted

Study results publicly available

September 19, 2024

Completed
Last Updated

September 19, 2024

Status Verified

September 1, 2024

Enrollment Period

11 months

First QC Date

June 2, 2021

Results QC Date

September 8, 2023

Last Update Submit

September 6, 2024

Conditions

Keywords

COVIDBalance

Outcome Measures

Primary Outcomes (1)

  • Motor Balance as Measured by Timed Up and Go (TUG)

    The TUG measures mobility, motor balance, walking ability, and falls risk based on how long it takes the patient to stand up, walk 10 feet, turn around, walk back, and sit down. \< 10 seconds = normal, \< 20 seconds = good mobility; can walk outside alone; does not require a walking aid, \< 30 seconds = walking and balance problems; cannot walk outside alone; requires walking aid.

    Baseline

Secondary Outcomes (2)

  • Sensory Influence on Balance as Measured by Modified Clinical Test of Sensory Interaction in Balance (mCTSIB)

    Baseline

  • Balance Confidence as Measured by Activities Specific Balance Confidence (ABC) Scale

    Baseline

Study Arms (1)

Patients who have tested positive for COVID-19

Patients who are designated as "COVID recovered" in the electronic medical record and who fit the inclusion criteria.

Other: Balance assessments

Interventions

There is no formal intervention in this study. The investigators will only be completing balance assessments with no follow-up visit.

Patients who have tested positive for COVID-19

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Subjects will be adults who have primary or secondary diagnosis of COVID-19 during hospitalization and off COVID-19 isolation and be receiving care in an acute inpatient hospital (Duke University Health System).

You may qualify if:

  • Age \> 18 years
  • Primary or secondary diagnosis of COVID- 19 during hospitalization and off COVID-19 isolation
  • Receiving care in acute inpatient
  • Ability to ambulate 20' with or without an assistive device without dropping \>10% of resting oxygen saturation (determined from existing physical therapy evaluation)
  • Ability to stand with no more than contact guard assistance (determined from existing physical therapy evaluation)
  • Not requiring use of mechanical ventilation
  • Minimum resting oxygen saturation of 88% with or without supplemental oxygen
  • No neurological or orthopedic dysfunction that would affect balance
  • Cognitively intact and able to follow directions and provide consent

You may not qualify if:

  • History of 2 or more falls in the year prior to COVID-19 diagnosis or history of balance dysfunction

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Duke University Health System

Durham, North Carolina, 27615, United States

Location

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Results Point of Contact

Title
Ashley Poole
Organization
Duke University

Study Officials

  • Ashley Poole

    Duke Health

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 2, 2021

First Posted

June 4, 2021

Study Start

July 23, 2021

Primary Completion

June 22, 2022

Study Completion

June 22, 2022

Last Updated

September 19, 2024

Results First Posted

September 19, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations